Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-73

Sarepta raised a huge amount, when they already had big cash reserves, at a time when their trials were failing and ANP was showing great results.

akki just because u posted about similar wording in sareptas previous raise doesnt mean ur the wizard, and the only one who noticed that. Theres a lot other posters may discover yet not post because it doesnt help their investment. Calling yourself a hero for that repeatedly... comon. Reality check and salt mouthwash for yourself feels appropriate.

why did sarepta raise so much??? We still have no answer. Feel free to predict that.